Journal article
Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh
A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make them more attractive for use against endemic and epidemic cholera. The researchers conducted an efficacy trial of a single dose of the killed oral cholera vaccine Shanchol, which is currently given in a two-dose schedule, in an urban area in which cholera is highly endemic.
Authors
- John D. Clemens
- Yasmin A. Begum
- Arifuzzaman Khan
- Afroza Akter
- M.Phil
- Muhammad Asaduzzaman
- Iqbal A. Khan
- M.Med
- Amit Saha
- Ashraful I. Khan
- Fahima Chowdhury
- Mohammad Ali
- Thomas F. Wierzba
- Taufiqur R. Bhuiyan
- Farhana Khanam
- Mohiul I. Chowdhury
- Ajit P. Singh
- Sachin N Desai
- Alejandro Cravioto
- Alamgir Kabir
- Nirod C Saha
- Ashraf U. Siddik
- Deok R. Kim
- Young A. You
- Shah A. Siddique
- Anisur Rahman
- Atique I. Chowdhury
- Taufiqul Islam
- Firdausi Qadri
Languages
- English
Publication year
2016
Journal
NJEM
Volume
374
Issue
18
Type
Journal article
Categories
- Vaccines & delivery devices
Diseases
- Cholera
Countries
- Bangladesh
Tags
- Vaccine trials
WHO Regions
- South-East Asia Region
